Your browser doesn't support javascript.
loading
Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8+ T Cells.
Chen, Chang-Yu; Ueha, Satoshi; Ishiwata, Yoshiro; Shichino, Shigeyuki; Yokochi, Shoji; Yang, De; Oppenheim, Joost J; Ogiwara, Haru; Deshimaru, Shungo; Kanno, Yuzuka; Aoki, Hiroyasu; Ogawa, Tatsuro; Shibayama, Shiro; Matsushima, Kouji.
Afiliação
  • Chen CY; Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
  • Ueha S; Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Ishiwata Y; Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
  • Shichino S; Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Yokochi S; Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
  • Yang; Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Oppenheim JJ; Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
  • Ogiwara H; Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Deshimaru S; Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
  • Kanno Y; Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Aoki H; Cancer and Inflammation Program, Center for Cancer Research, NCI at Frederick, Frederick, Maryland.
  • Ogawa T; Cancer and Inflammation Program, Center for Cancer Research, NCI at Frederick, Frederick, Maryland.
  • Shibayama S; Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
  • Matsushima K; Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Cancer Immunol Res ; 9(10): 1214-1228, 2021 10.
Article em En | MEDLINE | ID: mdl-34344641
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Proteína HMGN1 / Antígeno B7-H1 / Alarminas / Neoplasias Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Proteína HMGN1 / Antígeno B7-H1 / Alarminas / Neoplasias Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article